Pharmalot -- Two months ago, Pfizer signaled interest in selling or spinning off some of its so-called ‘non-core’ businesses - those that are not involved in brand-name pharmaceuticals. These would include the nutritionals, consumer health and animal health units, and possibly a generics operation. A business that makes capsules has already been sold (back story here and here).
